Researchers at the University of British Columbia are developing a wearable device to help Parkinson’s disease patients manage their L-dopa medication more effectively. The study, led by Dr. Martin McKeown, uses the Empatica EmbracePlus wristband, which tracks physiological data such as heart rate and skin temperature, to predict when a patient’s medication is wearing off. This personalized approach aims to alert patients to take their next dose before symptoms appear, improving medication timing and overall quality of life.
An Individualized Multi-modal Approach for Detection of Medication “Off” Episodes in Parkinson’s Disease via Wearable Sensors
read more
